AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18026625
Drug: Group 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1: Vaccine stored within the cold chain and administered in township hospitals
Trial: 18026625
Drug: Group 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2: Vaccine stored out of the cold chain in villages and administered by village-based health workers
Trial: 18026625
Drug: Group 3:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3: Same strategy as group 2, but vaccine packaged in a prefilled injection device
Trial: 16051334
Drug: Paclitaxel combined
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel combined with fixed doses of carboplatin
Trial: 9700123
Drug: Antithrombin (AT)
RxNorm normalized name: antithrombin III
DrugBank: Antithrombin gamma (DB16094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombin (AT) therapy
Trial: 7923999
Drug: Lactulose (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (1 g/100 kcals to a maximum of 28 g/d)
Trial: 2645313
Drug: Synthetic GnRH
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic GnRH (7.5, 25, 75, and 250 ng/kg) iv at 2-h intervals after long term pulsatile GnRH administration
Trial: 2645313
Drug: Synthetic GnRH
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic GnRH (various doses)
Trial: 21856044
Drug: Peripheral intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral intravenous access
Trial: 28100482
Drug: Subtenon injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subtenon injection of 0.1 mL of 0.01% MMC
Trial: 17032001
Drug: High-L spinach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-L spinach ('Spinner')
Trial: 17032001
Drug: Low-L spinach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-L spinach ('Springer')
Trial: 15483415
Drug: Anti-TNF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF therapy (neutralizing antibody directed against tumor necrosis factor) at varying doses for 6, 24, or 48 hours
Trial: 15483415
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no anti-TNF therapy)
Trial: 9084461
Drug: rhPTH(1-84) at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhPTH(1-84) at doses 0.02 to 5.0 micrograms.kg-1
Trial: 9084461
Drug: rhPTH(1-84) at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhPTH(1-84) at doses > 2.5 micrograms.kg-1
Trial: 9084461
Drug: rhPTH(1-84) at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhPTH(1-84) at doses > or = 1.5 micrograms.kg-1
Trial: 3278068
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg suppositories twice daily
Trial: 3278068
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 1000 mg effervescent tablets three times daily
Trial: 24427287
Drug: Thrombin-reactive phages
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin-reactive phages selected using biotinylated anti-thrombin antibodies and streptavidin-coated magnetic beads.
Trial: 17617557
Drug: 20 G
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 G Optiva i.v. plastic cannula
Trial: 9698949
Drug: Single-injection spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-injection spinal anaesthesia (SA)
Trial: 751811
Drug: Insight-oriented treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insight-oriented treatment
Trial: 751811
Drug: Problem-Solving therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving therapy
Trial: 7034929
Drug: MTX 5
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX 5 g/m2
Trial: 7034929
Drug: MTX 500
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX 500 mg/m2
Trial: 7034929
Drug: MTX 50
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX 50 mg/m2
Trial: 7034929
Drug: MTX (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX (all doses)
Trial: 19938332
Drug: Oral functional
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral functional training
Trial: 19938332
Drug: Tongue pressure
RxNorm normalized name: beef tongue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongue pressure and oral diadochokinesis (pronouncing 'ka')
Trial: 15351752
Drug: Routine influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine influenza vaccination (injected or intranasal spray)
Trial: 15351752
Drug: Injectable vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable vaccine for infants (6 months to 35 months)
Trial: 10414674
Drug: Ketoprofen, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen, 100 mg, three times a day
Trial: 10414674
Drug: Acetaminophen, 1
RxNorm normalized name: Acetaminophen, 120 mg/5 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen, 1 g, three times a day
Trial: 8649915
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg dexamethasone syrup
Trial: 8649915
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg dexamethasone syrup
Trial: 8649915
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg dexamethasone syrup
Trial: 2180259
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low dose bromocriptine
Trial: 2180259
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage regimen of bromocriptine
Trial: 2180259
Drug: Maintenance dosage
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance dosage of bromocriptine (5 mg-15 mg daily)
Trial: 25586468
Drug: Rindopepimut and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rindopepimut and standard adjuvant temozolomide chemotherapy
Trial: 23533460
Drug: D&G herbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D&G herbal capsules 1 gm/day
Trial: 23533460
Drug: D&G herbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D&G herbal capsules 2 gm/day
Trial: 21942183
Drug: Medication (Glibenclamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Glibenclamide 2.5‐7.5 mg/time, 1‐2 times/d for 12 weeks)
Trial: 21942183
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between Acupuncture and Medication
Trial: 19826060
Drug: dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dexlansoprazole MR 90 mg
Trial: 19826060
Drug: dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dexlansoprazole MR 300 mg
Trial: 7829780
Drug: MS-857 (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS-857 (15 mg, n = 10)
Trial: 2194417
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics (neomycin and erythromycin)
Trial: 2194417
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oral and intravenous antibiotics
Trial: 369735
Drug: Flunisolide nasal
RxNorm normalized name: flunisolide nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunisolide nasal spray (0.025% solution, 200 microgram daily dosage)
Trial: 24507118
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual (TAU), no intervention
Trial: 20801500
Drug: Ivabradine (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivabradine (titrated to a maximum of 7.5 mg twice daily)
Trial: 15664719
Drug: Increased 12-step
RxNorm normalized name: STEP 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased 12-step participation during the first 3 months of treatment
Trial: 15664719
Drug: Individual Drug
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual Drug Counseling based on a 12-step model
Trial: 10579471
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL double-strength grapefruit juice
Trial: 1751081
Drug: Na+ modeling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Na+ modeling (Na+ = 149 meq/L)
Trial: 1751081
Drug: Standard Na+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Na+ dialysate (Na+ = 140 meq/L)
Trial: 24869973
Drug: PLD (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLD (30 mg/m(2)) and trabectedin (1.1 mg/m(2)) in overweight and obese patients (n = 48)
Trial: 24869973
Drug: PLD (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLD (30 mg/m(2)) and trabectedin (1.1 mg/m(2)) in normal weight patients (n = 26)
Trial: 12117660
Drug: Combined SCG
RxNorm normalized name: microcrystalline cellulose 102 SCG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined SCG (2 mg four times daily) and fluticasone propionate powder 50 microg b.i.d. (group FS)
Trial: 10672387
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied over skin areas corresponding to injection sites one hour before nerve blocks, placebo intravenous normal-saline injection 2 minutes before the first nerve block.
Trial: 10672387
Drug: Intravenous alfentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alfentanil 10 micrograms.kg‐1, placebo cream applied.
Trial: 10672387
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream and intravenous normal-saline at similar time intervals prior to the nerve blocks.
Trial: 7485665
Drug: Not using
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not using condoms due to starting oral contraceptive pill regimens
Trial: 4053698
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg twice daily for seven days
Trial: 4053698
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg twice daily for four days
Trial: 29343256
Drug: 3 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g/d green cardamom for 10 weeks
Trial: 21466944
Drug: Linking and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linking and retaining a person in treatment
Trial: 3128309
Drug: Oral Ftorafur
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Ftorafur (1 g/m2/day for 21 days)
Trial: 3128309
Drug: Intravenous 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 5-fluorouracil (5-FU) (500 mg/m2/day for 5 days)
Trial: 28695324
Drug: Almonds (56
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almonds (56 g daily)
Trial: 25514559
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg catechins
Trial: 25514559
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg theaflavins
Trial: 25514559
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg theaflavins
Trial: 25514559
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of theaflavins
Trial: 31977817
Drug: Romosozumab (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Romosozumab (70 mg, 140 mg, 210 mg)
Trial: 30802304
Drug: Selective decontamination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective decontamination of the digestive tract (SDD) with oral colistin, tobramycin, and amphotericin B
Trial: 30802304
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving intravenous cefazolin and metronidazole for perioperative prophylaxis
Trial: 28881549
Drug: Cholera vaccine
RxNorm normalized name: Cholera Vaccine
DrugBank: Vibrio cholerae CVD 103-HgR strain live antigen (DB14443)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholera vaccine infused with antacids
Trial: 20691481
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 300 mg/day (for inadequate responders)
Trial: 15492131
Drug: hs-CRP >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hs-CRP > or = 3.0 mg/L
Trial: 11566622
Drug: Local administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local administration of IL-1beta (10 ng/ml, once a day for 7 days)
Trial: 8181260
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg oral pirenzepine
Trial: 29995697
Drug: AnonVT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AnonVT with the nonvasodilating beta‐blocker metoprolol
Trial: 28157412
Drug: Oral jet
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral jet nebulizer
Trial: 22448907
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (physical therapy, manual stretching)
Trial: 19507268
Drug: Tianwang Buxin
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tianwang Buxin Pills (TBPs)
Trial: 15139870
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance (n = 91) with monthly 1 hour/week of psychosocial therapy during the first 6 months
Trial: 15139870
Drug: 180-day detoxification
RxNorm normalized name: ARTEMISIA VULGARIS ROOT 4.5 mg in 30 mg / CINNAMON 3 mg in 30 mg / CALENDULA OFFICINALIS FLOWER 4.5 mg in 30 mg / MENTHA PIPERITA LEAF 9 mg in 30 mg TOPICAL LIQUID [HOUKEA Lymphatic Detoxification Anti-Inflammatory Slimming Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180-day detoxification (n = 88) with 3 hours/week of psychosocial therapy and 14 education sessions during the first 6 months
Trial: 9648550
Drug: Bromocriptine (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (low-dose D2 dopamine receptor agonist)
Trial: 7988261
Drug: Cisplatin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (75 mg/m2 on days 1 and 29) and fluorouracil (1 g/m2 for 24 h as continuous infusion on days 1 to 4 and 29 to 32) with thoracic radiation (30 Gy in 15 fractions on days 1 to 19)
Trial: 2567439
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at points specific for the treatment of substance abuse
Trial: 30921645
Drug: Irinotecan hydrochloride
RxNorm normalized name: Irinotecan Hydrochloride
DrugBank: Irinotecan (DB00762)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Irinotecan hydrochloride liposome injection (IHLI)
Trial: 28679449
Drug: Abatacept 3
RxNorm normalized name: Abatacept
DrugBank: Abatacept (DB01281)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Abatacept 3 mg/kg on day 1, 15, and 29, followed by 10 mg/kg every 28 days for 5 months
Trial: 26596672
Drug: Afatinib alone
RxNorm normalized name: Afatinib
DrugBank: Afatinib (DB08916)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Afatinib alone 40 mg orally once per day
Trial: 26596672
Drug: Afatinib plus
RxNorm normalized name: Afatinib
DrugBank: Afatinib (DB08916)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Afatinib plus vinorelbine 40 mg per day plus intravenous vinorelbine 25 mg/m2 once per week
Trial: 23808999
Drug: Berberine hydrochloride
RxNorm normalized name: Berberine Hydrochloride
DrugBank: Berberine (DB04115)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berberine hydrochloride (500 mg) three times daily before meals for 3 months
Trial: 29180454
Drug: Sacubitril/valsartan (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sacubitril/valsartan (8 weeks treatment)
Trial: 15723448
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 mg every 12 hours for a total of 5 doses)
Trial: 15723448
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg every 12 hours for a total of 5 doses)
Trial: 3120345
Drug: Placebo four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo four times daily
Trial: 7625622
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms of misoprostol twice daily
Trial: 7625622
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms of misoprostol three times daily
Trial: 7625622
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms of misoprostol four times daily
Trial: 7625622
Drug: Misoprostol twice
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol twice daily vs. Misoprostol three times daily
Trial: 7625622
Drug: Misoprostol four
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol four times daily
Trial: 7625622
Drug: Misoprostol twice
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol twice daily and three times daily
Trial: 343500
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg nitrazepam
Trial: 21098507
Drug: Phenylbutyrate therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylbutyrate therapy
Trial: 19212615
Drug: Transcatheter arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcatheter arterial infusion (TAI) of 120 mg/body cisplatin twice a month at an interval of 4 weeks
Trial: 12439700
Drug: Amifostine (740
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (740 mg/m²) before HDM (200 mg/m²)
Trial: 25180558
Drug: Additional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional therapy sessions (AT)
Trial: 21136031
Drug: Rehabilitation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation therapy for 3 months
Trial: 19916293
Drug: Acupuncture (thick-needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (thick-needle subcutaneous penetration of Shendao (GV 11), retained for 4 h/time, once daily, 5 times/week)
Trial: 19916293
Drug: Medication (Levocetirizine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Levocetirizine Hydrochloride tablets, 5 mg/time, once daily for first two weeks, then once every other day in the 3rd and 4th weeks, and once every 3 days in the last two weeks)
Trial: 15182272
Drug: Salbutamol 100
RxNorm normalized name: Salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol 100 microg/puff, 12 puffs daily
Trial: 15182272
Drug: Ipratropium 20
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium 20 microg/puff, 12 puffs daily
Trial: 9660095
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg melatonin
Trial: 8018001
Drug: Bisoprolol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 2.5 mg/d and Hydrochlorothiazide 6.25 mg/d
Trial: 8018001
Drug: Hydrochlorothiazide 6.25
RxNorm normalized name: hydrochlorothiazide 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 6.25 mg/d
Trial: 789844
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (100 mug three times daily)
Trial: 21877102
Drug: Dyskinetic PD
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dyskinetic PD subjects off L-dopa
Trial: 21877102
Drug: Non-dyskinetic PD
RxNorm normalized name: Poly Hist PD
DrugBank: Thonzylamine (DB11235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-dyskinetic PD subjects off L-dopa
Trial: 8550745
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate infusion
Trial: 8550745
Drug: Sham infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham infusion (sodium chloride)